BCG-MEDAC, powder and solvent for suspension intravesical bottle, 50 ml, CIP 3400930018644
Active ingredients: BACTÉRIE BCG LYOPHILISÉ
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for suspensionbottle, 50 ml, CIP 3400930018644intravésicale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BCG-MEDAC, poudre et solvant pour suspension intravésicale
- Pharmaceutical form
- poudre et solvant pour suspension
- Route of administration
- intravésicale
- Presentation description
- 1 flacon(s) en verre - 1 poche(s) APP : advanced polypropylène de 50 ml avec connecteur(s) pour flacon avec connecteur(s) Luer-Lock pour cathéter avec cathéter(s)
- Marketing authorisation holder
- MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Feb 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60973899CIP73001864CIP133400930018644Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BACTÉRIE BCG LYOPHILISÉpoudre | 200 millions à 3000 millions unités viables · un flacon après reconstitution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.